PLATELET-RICH FIBRIN; BB RHPDGF-BB; BIO-OSS; HISTOLOGIC EVALUATION; REGENERATIVE THERAPY; CLINICAL-OUTCOMES; BARRIER MEMBRANE; FLAP DEBRIDEMENT; COLLAGEN; MULTICENTER
The purpose of this study was to assess the healing of periodontal intrabony defects treated using enamel matrix derivative (EMD) after at least 5 years of follow-up. Six patients with seven intrabony defects were included in the study. Treatment with EMD yielded a mean clinical attachment level gain of 4.3±2.4 mm, a mean probing depth reduction of 4.7±2.1 mm and a mean gingival recession increase of 0.7±1.8 mm. Re-entry measurements showed a complete resolution of the intrabony defect in 5 cases, while in 2 cases a residual intrabony component was recorded. The present study indicates that treatment using EMD provided good clinical outcomes maintained in most cases over a period of at least 5 years.
Treatment of Periodontal Intrabony Defects Using Enamel Matrix Derivative: Surgical Reentry After an Observation Period of at Least 5 Years
Isola, Gaetano
Writing – Review & Editing
;
2019-01-01
Abstract
The purpose of this study was to assess the healing of periodontal intrabony defects treated using enamel matrix derivative (EMD) after at least 5 years of follow-up. Six patients with seven intrabony defects were included in the study. Treatment with EMD yielded a mean clinical attachment level gain of 4.3±2.4 mm, a mean probing depth reduction of 4.7±2.1 mm and a mean gingival recession increase of 0.7±1.8 mm. Re-entry measurements showed a complete resolution of the intrabony defect in 5 cases, while in 2 cases a residual intrabony component was recorded. The present study indicates that treatment using EMD provided good clinical outcomes maintained in most cases over a period of at least 5 years.File | Dimensione | Formato | |
---|---|---|---|
Iorio-Siciliano et al 2019.pdf
solo gestori archivio
Tipologia:
Documento in Post-print
Dimensione
534.14 kB
Formato
Adobe PDF
|
534.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.